Get started
Author

Gürdal Şahin

Observed names: G. Sahin, Gurdal Sahin, Gürdal Sahin, Gürdal ŞAHİN, Sahin, Gurdal, Sahin, Gürdal
Observed institutions: Lund University, Hässleholms Sjukhus, Hacettepe University Hospital, Skåne University Hospital, Region Skåne, Hacettepe University
ORCID: 0000-0002-9998-5983
Observed ORCID: 0000-0002-9998-5983
OpenAlex ID: A5033799839
α-Synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in early-stage Parkinson's disease
2012 · Isabel Lastres-Becker, Ayse Ulusoy, et al. · Human Molecular Genetics · 270
Neuroinflammation in Parkinson"s Disease and its Treatment Opportunities
2022 · Elif Çınar, Banu Cahide Tel, et al. · Balkan Medical Journal · 89
PDF
Functional Convergence of Dopaminergic and Cholinergic Input Is Critical for Hippocampus-Dependent Working Memory
2008 · Liselijn A. B. Wisman, Gurdal Sahin, et al. · Journal of Neuroscience · 77
PDF
Dose Optimization for Long-term rAAV-mediated RNA Interference in the Nigrostriatal Projection Neurons
2009 · Ayse Ulusoy, Gurdal Sahin, et al. · Molecular Therapy · 73
Primary angiitis of the central nervous system and silent cortical hemorrhages.
2002 · Hakan Ay, Gürdal Sahin, et al. · PubMed · 61
Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease
2013 · Fabia Febbraro, Gurdal Sahin, et al. · Neurobiology of Disease · 56
Presynaptic dopaminergic compartment determines the susceptibility to L-DOPA–induced dyskinesia in rats
2010 · Ayse Ulusoy, Gurdal Sahin, et al. · Proceedings of the National Academy of Sciences · 53
Design of a Single AAV Vector for Coexpression of TH and GCH1 to Establish Continuous DOPA Synthesis in a Rat Model of Parkinson's Disease
2012 · Erik Cederfjäll, Gurdal Sahin, et al. · Molecular Therapy · 37
PDF
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease
2013 · Erik Cederfjäll, Nathalie Nilsson, et al. · Scientific Reports · 26
PDF
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study
2023 · Messoud Ashina, Dimos D. Mitsikostas, et al. · Cephalalgia · 21
PDF
Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
2014 · Gurdal Sahin, Lachlan H. Thompson, et al. · PLoS ONE · 21
PDF
Management of Vertebral Stenosis Complicated by Presence of Acute Thrombus
2006 · Murat Canyigit, Anil Arat, et al. · CardioVascular and Interventional Radiology · 15
Acute bilateral cerebellar infarction in the territory of the medial branches of posterior inferior cerebellar arteries
2001 · Gunfer Gurer, Gurdal Sahin, et al. · Clinical Neurology and Neurosurgery · 12
Posterior Leukoencephalopathy and Nephrotic Syndrome: Just a Coincidence?
2004 · Duygu Yazgan Aksoy, Mustafa Arici, et al. · The American Journal of the Medical Sciences · 11
Tremor evaluation using smartphone accelerometry in standardized settings
2022 · Gürdal Sahin, Pär Halje, et al. · Frontiers in Neuroscience · 10
Focal EEG Findings in Juvenile Absence Syndrome and the Effect of Antiepileptic Drugs
2008 · F. Irsel Tezer, Gurdal Sahin, et al. · Clinical EEG and Neuroscience · 10
Familial Parkinsonism with Apathy, Depression and Central Hypoventilation (Perry’s Syndrome)
2002 · Bülent Elibol, Tomonori Kobayashi, et al. · Advances in behavioral biology · 10
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study
2025 · Messoud Ashina, Dimos D. Mitsikostas, et al. · Neurological Sciences · 8
PDF
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
2011 · Erik Cederfjäll, Gurdal Sahin, et al. · Neurobiology of Disease · 7
Abstracts from the 18 th European Headache Congress (EHC): Rotterdam, The Netherlands. 4-7 December 2024
2025 · Uzun, Sena, Nerjovaj, Pashtrik, et al. · The Journal of Headache and Pain · 6
Constipation as a possible predictor of poor treatment response in chronic migraine: A retrospective study of anti-calcitonin gene-related peptide (anti-CGRP) monoclonal antibodies and the impact of switching
2024 · Sena Uzun, Ulf Frejvall, et al. · Cephalalgia Reports · 3
Spectral analysis of lithium tremor
2020 · Gul Yalcin-Cakmakli, Yavuz Ayhan, et al. · Nöro Psikiyatri Arşivi · 2
PDF
A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?
2023 · Sena Uzun, Ulf Frejvall, et al. · Frontiers in Neurology · 1
PDF
[Episodes with goose bumps caused by anti-LGI-1 encephalitis].
2020 · Jessica Johansson Lindgren, Magnus Esbjörnsson, et al. · PubMed · 1
Long-term blood pressure changes in patients treated with anti-CGRP monoclonal antibodies: A retrospective real-world study
2026 · Sena Uzun, Elin Trulsson, et al. · Research Square
PDF
Works count: 39
Citation count: 880
H-index: 12
I10-index: 17
Year
Topic
Type